Ménière’s disease (MD) is an inner ear disorder characterized by a burden of symptoms and comorbidities, including migraine. In both disorders, ionic dysregulation may play a role as a predisposing factor. In recent years. aquaporins have been widely investigated, but the results are far from conclusive. We recently studied the genetics of ionic transporters and the hormone endogenous ouabain as predisposing factors for development of MD. In particular, we found two genetic polymorphisms associated with MD: 1) rs3746951, a missense variant (Gly180Ser) in the salt-inducible kinase-1 (SIK1) gene encoding a Na+, K+ ATPase; 2) rs487119, an intronic variant of gene SLC8A1 coding for a Na+, Ca++ exchanger (NCX-1). Ionic concentration in the brain also plays a role in the pathophysiology of migraine. In this brief review we summarize what has been published on MD and migraine.
AbouzariM., AbiriA. and DjalilianH.R., Successful treatment of a child with definite Meniere’s disease with the migraine regimen, Am J Otolaryngol40 (2019), 440–442.
2.
AlperS.L. and SharmaA.K., The SLC26 gene family of anion transporters and channels, Mol Aspects Med34 (2013), 494–515.
3.
BouzinovaE.V., HangaardL. and StaehrC., The α2 isoform Na, K-ATPase modulates contraction of rat mesenteric small artery via cSrc-dependent Ca2+sensitization, Acta Physiol (Oxf)224 (2018), e13059.
4.
CandreiaC., SchmuzigerN. and GurtlerN., Molecular analysis of aquaporin genes 1 to 4 in patients with Ménière’s Disease, Cell Physiol Biochem26 (2010), 787–792.
5.
Cavalcante-SilvaL.H.A., LimaE.A., CarvalhoD.C.M., de Sales-NetoJ.M., et al., Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain, Front Physiol8 (2017), 895.
6.
DegermanE., RauchU., GoranssonO., LindbergS., HultgardhA. and MagnussonM., Identification of new signaling components in the sensory epithelium of human saccule, Front Neurol2 (2011), e48.
7.
DucrosA., DenierC., JoutelA., et al., The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel, N Engl J Med345 (2001), 17–24.
8.
EckhardA.H., ZhuM.Y., O’MalleyJ.T., WilliamsG.H., LoffingJ., RauchS.D., et al., Inner ear pathologies impair sodium-regulated ion transport in Meniere’s disease, Acta Neuropathol137 (2018), 343–357.
9.
FlookM., FrejoL, Gallego-MartinezA., et al., Differential proinflammatory signature in vestibular migraine and Meniere Disease, Front Immunol10 (2019), 1229.
10.
FrejoL., GieglingI., TeggiR., Lopez-EscamezJ.A. and RujescuD., Genetics of vestibular disorders: pathophysiological insights, J Neurol263 (2016), 45–53.
11.
FrejoL., Martin-SanzE., TeggiR., TrinidadG., Soto-VarelaA., et al., Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross-sectional study with cluster analysis, Clin Otolaryngol42 (2017), 1172–1180.
12.
FrejoL., Soto-VarelaA., Santos-PerezS., AranI., Batuecas CaletrioA., et al., Clinical subgroups in bilateral Meniere Disease, Front Neurol7 (2016), 182.
13.
FrejoL., RequenaT., OkawaS., et al., Regulation of Fn14 receptor and NF-κB underlies inflammation in Meniere’s Disease, Front Immunol8 (2017), 1739.
14.
FrejoL., Gallego-MartinezA., RequenaT., et al., Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease, Sci Rep8 (2018), 5974.
15.
FriedmannI., FraserG.R. and FroggattP., Pathology of the ear in the cardioauditory syndrome of Jervell and Lange– Nielsen (recessive deafness with electrocardiographic abnormalities, J Laryngol Otol80 (1966), 451–470.
16.
GrossN.B., AbadN., LichtsteinD., et al., Endogenous Na+,+-ATPase inhibitors and CSF [Na+] contribute to migraine formation, PLOS one14 (2019), e0218041.
17.
GulbenkianS., UddmanR. and EdvinssonL., Neuronal messengers in the human cerebral circulation, Peptides22 (2001), 995–1007.
18.
HarringtonM.G., FontehA.N., HarakakiX., et al., Capillary endothelial Na(+), K(+), ATPase transporter homeostasis and a new theory for migraine pathophysiology, Headache50 (2010), 459–478.
19.
HarringtonM.G. and FontehA.H., Cerebrospinal fluid sodium increases in migraine, Headache46 (2006), 1128–1135.
20.
HeapR.E., HopeA.G., PearsonL.A., et al., Identifying Inhibitors of Inflammation: A Novel High-Throughput MALDI-TOF Screening Assay for Salt-Inducible Kinases (SIKs). SLAS Discov22 (2017), 1193–1202.
21.
KayaI., EraslanS., TarhanC., et al., Can verapamil be effective in controlling vertigo and headache attacks in vestibular migraine accompanied with Meniere’s disease? A preliminary study, J Neurol266 (2019), 562–564.
22.
KirschV., Becker-BenseS., BermanA., KierigE., Ertl-WagnerB. and DieterichM., Transient endolymphatic hydrops after an attack of vestibular migraine: a longitudinal single case study, J Neurol265 (2018), 51–53.
23.
KoE.A., HanJ., JungI.D., et al., Physiological roles of+channels in vascular smooth muscle cells, J Smooth muscle Res44 (2008), 65–81.
24.
LempertT., OlesenJ., FurmanJ., WaterstonJ., SeemungalB., et al., Vestibular migraine: diagnostic criteria, J Vest Res22 (2012), 167–172.
25.
Lopes de CarvalhoK., SartoratoE.L., da Silva-CostaS.M., de Macedo AdamovN.S. and GanançaF.F., Ménière’s disease: molecular analysis of aquaporins 2, 3 and potassium channel KCNE1 genes in Brazilian patients, Otol Neurotol37 (2016), 1117–1121.
Lopez-EscamezJ.A., DlugaiczykJ., JacobsJ., LempertT., et al., Accompanying symptoms overlap during attacks in Menière’s Disease and Vestibular Migraine, Front Neurol15 (2014), e265.
28.
MallurP.S., WeisstuchA., PfisterM., et al., Aquaporin-2 and -4: single nucleotide polymorphisms in Ménière’s disease patients, Audiol Med8 (2010), 18–23.
29.
MeyerM.M., SchmidtA., BenrathJ., et al., Cerebral sodium (23Na) magnetic resonance imaging in patients with migraine - a case-control study, Eur Radiol29 (2019), 7055–7062.
30.
MoriN., MiyashitaT., InamotoR., MatsubaraA., MoriT., AkiyamaK. and HoshikawaH., H Ion transport its regulation in the endolymphatic sac: suggestions for clinical aspects of Meniere’s disease, Eur Arch Otolaryngol274 (2017), 1813–1820.
31.
MurofushiT., TsubotaM., KitaoK. and YoshimuraE., Simultaneous presentation of definite vestibular migraine and definite Ménière’s disease: overlapping syndrome of two diseases, Front Neurol9 (2018), e749.
32.
NosedaR. and BursteinR., Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain, Pain154(Suppl 1) (2013), s44–53.
33.
PyykköI., ManchaiahV., FärkkiläM., KentalaE. and ZouJ., Association between Ménière’s disease and vestibular migraine, Auris Nasus Larynx46 (2019), 724–733.
34.
RadtkeA., LempertT., GrestyM.A., BrookesG.B., BronsteinA.M. and NeuhauserH., Migraine and Meniere’s disease: is there a link?Neurology59 (2002), 1700–1704.
35.
RusselM.B., Is migraine a genetic illness? The various forms of migraine share a common genetic cause, Neurol Sci29 (2008), s52–4.
36.
ShinC.H., KimY., YooM.H., KimT.S., ParkJ.W., KangB.C. and ParkH.J., Management of Ménière’s Disease: How Does the Coexistence of Vestibular Migraine Affect Outcomes?Otol Neurotol40 (2019), 666–673.
37.
SugiuraM., SatoE., NakashimaT., et al., Long-term follow-up in patients with Pendred syndrome: vestibular, auditory and other phenotypes, Eur Arch Otorhinolaryngol262 (2005), 737–743.
38.
TeggiR., ColomboB., AlberaR., Asprella LibonatiG., et al., Clinical features, familial history, and migraine precursors in patients with definite vestibular migraine: The VM-Phenotypes projects, Headache58 (2018), 534–544.
39.
TeggiR., ZagatoL., Delli CarpiniS., CitterioL., CassandroC., AlberaR., YangW.Y., StaessenJ.A., BussiM., ManuntaP. and LanzaniC., Genetics of ion homeostasis in Ménière’s disease, Eur Arch Otorhinolaryngol274 (2017), 757–63.
40.
TeggiR., LanzaniC., ZagatoL., Delli CarpiniS., ManuntaP., BianchiG. and BussiM., Gly460Trp alpha-adducin mutation as a possible mechanism leading to endolymphatic hydrops in Ménière’s syndrome, Otol Neurotol29 (2008), 824–828.
41.
TeggiR., Delli CarpiniS. and ZagatoL., Endolymphatic hydrops and ionic transporters: genetic and biohumoral aspects, J Neurol (Suppl)266 (2019), 47–51.
42.
YamadaT., OgiK., SakashitaM., et al., Toll-like receptor ligands induce cytokine and chemokine production in human inner ear endolymphatic sac fibroblasts, Auris Nasus Larynx44 (2017), 398–403.
